Dopamine depletion impairs precursor cell proliferation in Parkinson disease
Cerebral dopamine depletion is the hallmark of Parkinson disease. Because dopamine modulates ontogenetic neurogenesis, depletion of dopamine might affect neural precursors in the subependymal zone and subgranular zone of the adult brain. Here we provide ultrastructural evidence showing that highly p...
Gespeichert in:
Veröffentlicht in: | Nature neuroscience 2004-07, Vol.7 (7), p.726-735 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 735 |
---|---|
container_issue | 7 |
container_start_page | 726 |
container_title | Nature neuroscience |
container_volume | 7 |
creator | Höglinger, Günter U Rizk, Pamela Muriel, Marie P Duyckaerts, Charles Oertel, Wolfgang H Caille, Isabelle Hirsch, Etienne C |
description | Cerebral dopamine depletion is the hallmark of Parkinson disease. Because dopamine modulates ontogenetic neurogenesis, depletion of dopamine might affect neural precursors in the subependymal zone and subgranular zone of the adult brain. Here we provide ultrastructural evidence showing that highly proliferative precursors in the adult subependymal zone express dopamine receptors and receive dopaminergic afferents. Experimental depletion of dopamine in rodents decreases precursor cell proliferation in both the subependymal zone and the subgranular zone. Proliferation is restored completely by a selective agonist of D2-like (D2L) receptors. Experiments with neural precursors from the adult subependymal zone grown as neurosphere cultures confirm that activation of D2L receptors directly increases the proliferation of these precursors. Consistently, the numbers of proliferating cells in the subependymal zone and neural precursor cells in the subgranular zone and olfactory bulb are reduced in postmortem brains of individuals with Parkinson disease. These observations suggest that the generation of neural precursor cells is impaired in Parkinson disease as a consequence of dopaminergic denervation. |
doi_str_mv | 10.1038/nn1265 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_18014948</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A185553435</galeid><sourcerecordid>A185553435</sourcerecordid><originalsourceid>FETCH-LOGICAL-c438t-50263769977ebd2af4a2a9fb9243da0c81584221344c6c4f8eef17fa6a9c9fed3</originalsourceid><addsrcrecordid>eNpdkVtrHSEURqW0NJc2PyEMfWjJw6TeRx9D2qSBAym9PIvH2R5MZnSiM5D--xrmQEjwQbeuvVnyIXRC8DnBTH2NkVAp3qBDIrhsSUfl23rGumslFfIAHZVyhzHuhNLv0QERRAusxSHafEuTHUOEpodpgDmk2IRxsiGXZsrgllxSbhwMQy3TEDxku0Kx-WnzfYilFn0oYAt8QO-8HQp83O_H6O_V9z-XP9rN7fXN5cWmdZypuRWYStZJrbsOtj21nltqtd9qyllvsVNEKE4pYZw76bhXAJ503kqrnfbQs2P0eZ1blR4WKLMZQ3lytBHSUgxRmHDNVQU_vQLv0pJjdTNUECY6TmSFzldoZwcwIfo0Z-vq6mEMLkXwod5fECWEYJyJ2nD2oqEyMzzOO7uUYm5-_3rJ7lVdTqVk8GbKYbT5nyHYPCVn1uQqeLpXXbYj9M_YPqoKfFmBUp_iDvLzX16N-g9OPp8g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>251357416</pqid></control><display><type>article</type><title>Dopamine depletion impairs precursor cell proliferation in Parkinson disease</title><source>MEDLINE</source><source>SpringerLink Journals</source><source>Nature Journals Online</source><creator>Höglinger, Günter U ; Rizk, Pamela ; Muriel, Marie P ; Duyckaerts, Charles ; Oertel, Wolfgang H ; Caille, Isabelle ; Hirsch, Etienne C</creator><creatorcontrib>Höglinger, Günter U ; Rizk, Pamela ; Muriel, Marie P ; Duyckaerts, Charles ; Oertel, Wolfgang H ; Caille, Isabelle ; Hirsch, Etienne C</creatorcontrib><description>Cerebral dopamine depletion is the hallmark of Parkinson disease. Because dopamine modulates ontogenetic neurogenesis, depletion of dopamine might affect neural precursors in the subependymal zone and subgranular zone of the adult brain. Here we provide ultrastructural evidence showing that highly proliferative precursors in the adult subependymal zone express dopamine receptors and receive dopaminergic afferents. Experimental depletion of dopamine in rodents decreases precursor cell proliferation in both the subependymal zone and the subgranular zone. Proliferation is restored completely by a selective agonist of D2-like (D2L) receptors. Experiments with neural precursors from the adult subependymal zone grown as neurosphere cultures confirm that activation of D2L receptors directly increases the proliferation of these precursors. Consistently, the numbers of proliferating cells in the subependymal zone and neural precursor cells in the subgranular zone and olfactory bulb are reduced in postmortem brains of individuals with Parkinson disease. These observations suggest that the generation of neural precursor cells is impaired in Parkinson disease as a consequence of dopaminergic denervation.</description><identifier>ISSN: 1097-6256</identifier><identifier>EISSN: 1546-1726</identifier><identifier>DOI: 10.1038/nn1265</identifier><identifier>PMID: 15195095</identifier><identifier>CODEN: NANEFN</identifier><language>eng</language><publisher>New York: Nature Publishing Group US</publisher><subject>Animal Genetics and Genomics ; Animals ; Antiparkinson Agents - therapeutic use ; Behavioral Sciences ; Biological Techniques ; Biomedical and Life Sciences ; Biomedicine ; Cell Differentiation ; Cell Division - drug effects ; Cell proliferation ; Cells, Cultured ; Diagnosis ; Dopamine ; Dopamine - deficiency ; Dopamine - physiology ; Dopamine Antagonists - pharmacology ; Drug Interactions ; Ependyma - cytology ; Ependyma - physiology ; Membrane Transport Proteins - metabolism ; Mice ; Mice, Inbred C57BL ; Neural Cell Adhesion Molecule L1 - metabolism ; Neurobiology ; Neurons - metabolism ; Neurons - pathology ; Neurons - ultrastructure ; Neurosciences ; Olfactory Bulb - cytology ; Olfactory Bulb - metabolism ; Parkinson Disease - drug therapy ; Parkinson Disease - metabolism ; Parkinson Disease - pathology ; Parkinson's disease ; Physiological aspects ; Rats ; Rats, Sprague-Dawley ; Risk factors ; Rodentia ; Tubulin - metabolism</subject><ispartof>Nature neuroscience, 2004-07, Vol.7 (7), p.726-735</ispartof><rights>Springer Nature America, Inc. 2004</rights><rights>COPYRIGHT 2004 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Jul 2004</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c438t-50263769977ebd2af4a2a9fb9243da0c81584221344c6c4f8eef17fa6a9c9fed3</citedby><cites>FETCH-LOGICAL-c438t-50263769977ebd2af4a2a9fb9243da0c81584221344c6c4f8eef17fa6a9c9fed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/nn1265$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/nn1265$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15195095$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Höglinger, Günter U</creatorcontrib><creatorcontrib>Rizk, Pamela</creatorcontrib><creatorcontrib>Muriel, Marie P</creatorcontrib><creatorcontrib>Duyckaerts, Charles</creatorcontrib><creatorcontrib>Oertel, Wolfgang H</creatorcontrib><creatorcontrib>Caille, Isabelle</creatorcontrib><creatorcontrib>Hirsch, Etienne C</creatorcontrib><title>Dopamine depletion impairs precursor cell proliferation in Parkinson disease</title><title>Nature neuroscience</title><addtitle>Nat Neurosci</addtitle><addtitle>Nat Neurosci</addtitle><description>Cerebral dopamine depletion is the hallmark of Parkinson disease. Because dopamine modulates ontogenetic neurogenesis, depletion of dopamine might affect neural precursors in the subependymal zone and subgranular zone of the adult brain. Here we provide ultrastructural evidence showing that highly proliferative precursors in the adult subependymal zone express dopamine receptors and receive dopaminergic afferents. Experimental depletion of dopamine in rodents decreases precursor cell proliferation in both the subependymal zone and the subgranular zone. Proliferation is restored completely by a selective agonist of D2-like (D2L) receptors. Experiments with neural precursors from the adult subependymal zone grown as neurosphere cultures confirm that activation of D2L receptors directly increases the proliferation of these precursors. Consistently, the numbers of proliferating cells in the subependymal zone and neural precursor cells in the subgranular zone and olfactory bulb are reduced in postmortem brains of individuals with Parkinson disease. These observations suggest that the generation of neural precursor cells is impaired in Parkinson disease as a consequence of dopaminergic denervation.</description><subject>Animal Genetics and Genomics</subject><subject>Animals</subject><subject>Antiparkinson Agents - therapeutic use</subject><subject>Behavioral Sciences</subject><subject>Biological Techniques</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Differentiation</subject><subject>Cell Division - drug effects</subject><subject>Cell proliferation</subject><subject>Cells, Cultured</subject><subject>Diagnosis</subject><subject>Dopamine</subject><subject>Dopamine - deficiency</subject><subject>Dopamine - physiology</subject><subject>Dopamine Antagonists - pharmacology</subject><subject>Drug Interactions</subject><subject>Ependyma - cytology</subject><subject>Ependyma - physiology</subject><subject>Membrane Transport Proteins - metabolism</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Neural Cell Adhesion Molecule L1 - metabolism</subject><subject>Neurobiology</subject><subject>Neurons - metabolism</subject><subject>Neurons - pathology</subject><subject>Neurons - ultrastructure</subject><subject>Neurosciences</subject><subject>Olfactory Bulb - cytology</subject><subject>Olfactory Bulb - metabolism</subject><subject>Parkinson Disease - drug therapy</subject><subject>Parkinson Disease - metabolism</subject><subject>Parkinson Disease - pathology</subject><subject>Parkinson's disease</subject><subject>Physiological aspects</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Risk factors</subject><subject>Rodentia</subject><subject>Tubulin - metabolism</subject><issn>1097-6256</issn><issn>1546-1726</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpdkVtrHSEURqW0NJc2PyEMfWjJw6TeRx9D2qSBAym9PIvH2R5MZnSiM5D--xrmQEjwQbeuvVnyIXRC8DnBTH2NkVAp3qBDIrhsSUfl23rGumslFfIAHZVyhzHuhNLv0QERRAusxSHafEuTHUOEpodpgDmk2IRxsiGXZsrgllxSbhwMQy3TEDxku0Kx-WnzfYilFn0oYAt8QO-8HQp83O_H6O_V9z-XP9rN7fXN5cWmdZypuRWYStZJrbsOtj21nltqtd9qyllvsVNEKE4pYZw76bhXAJ503kqrnfbQs2P0eZ1blR4WKLMZQ3lytBHSUgxRmHDNVQU_vQLv0pJjdTNUECY6TmSFzldoZwcwIfo0Z-vq6mEMLkXwod5fECWEYJyJ2nD2oqEyMzzOO7uUYm5-_3rJ7lVdTqVk8GbKYbT5nyHYPCVn1uQqeLpXXbYj9M_YPqoKfFmBUp_iDvLzX16N-g9OPp8g</recordid><startdate>20040701</startdate><enddate>20040701</enddate><creator>Höglinger, Günter U</creator><creator>Rizk, Pamela</creator><creator>Muriel, Marie P</creator><creator>Duyckaerts, Charles</creator><creator>Oertel, Wolfgang H</creator><creator>Caille, Isabelle</creator><creator>Hirsch, Etienne C</creator><general>Nature Publishing Group US</general><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7TM</scope><scope>7U7</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>RC3</scope></search><sort><creationdate>20040701</creationdate><title>Dopamine depletion impairs precursor cell proliferation in Parkinson disease</title><author>Höglinger, Günter U ; Rizk, Pamela ; Muriel, Marie P ; Duyckaerts, Charles ; Oertel, Wolfgang H ; Caille, Isabelle ; Hirsch, Etienne C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c438t-50263769977ebd2af4a2a9fb9243da0c81584221344c6c4f8eef17fa6a9c9fed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Animal Genetics and Genomics</topic><topic>Animals</topic><topic>Antiparkinson Agents - therapeutic use</topic><topic>Behavioral Sciences</topic><topic>Biological Techniques</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Differentiation</topic><topic>Cell Division - drug effects</topic><topic>Cell proliferation</topic><topic>Cells, Cultured</topic><topic>Diagnosis</topic><topic>Dopamine</topic><topic>Dopamine - deficiency</topic><topic>Dopamine - physiology</topic><topic>Dopamine Antagonists - pharmacology</topic><topic>Drug Interactions</topic><topic>Ependyma - cytology</topic><topic>Ependyma - physiology</topic><topic>Membrane Transport Proteins - metabolism</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Neural Cell Adhesion Molecule L1 - metabolism</topic><topic>Neurobiology</topic><topic>Neurons - metabolism</topic><topic>Neurons - pathology</topic><topic>Neurons - ultrastructure</topic><topic>Neurosciences</topic><topic>Olfactory Bulb - cytology</topic><topic>Olfactory Bulb - metabolism</topic><topic>Parkinson Disease - drug therapy</topic><topic>Parkinson Disease - metabolism</topic><topic>Parkinson Disease - pathology</topic><topic>Parkinson's disease</topic><topic>Physiological aspects</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Risk factors</topic><topic>Rodentia</topic><topic>Tubulin - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Höglinger, Günter U</creatorcontrib><creatorcontrib>Rizk, Pamela</creatorcontrib><creatorcontrib>Muriel, Marie P</creatorcontrib><creatorcontrib>Duyckaerts, Charles</creatorcontrib><creatorcontrib>Oertel, Wolfgang H</creatorcontrib><creatorcontrib>Caille, Isabelle</creatorcontrib><creatorcontrib>Hirsch, Etienne C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Genetics Abstracts</collection><jtitle>Nature neuroscience</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Höglinger, Günter U</au><au>Rizk, Pamela</au><au>Muriel, Marie P</au><au>Duyckaerts, Charles</au><au>Oertel, Wolfgang H</au><au>Caille, Isabelle</au><au>Hirsch, Etienne C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dopamine depletion impairs precursor cell proliferation in Parkinson disease</atitle><jtitle>Nature neuroscience</jtitle><stitle>Nat Neurosci</stitle><addtitle>Nat Neurosci</addtitle><date>2004-07-01</date><risdate>2004</risdate><volume>7</volume><issue>7</issue><spage>726</spage><epage>735</epage><pages>726-735</pages><issn>1097-6256</issn><eissn>1546-1726</eissn><coden>NANEFN</coden><abstract>Cerebral dopamine depletion is the hallmark of Parkinson disease. Because dopamine modulates ontogenetic neurogenesis, depletion of dopamine might affect neural precursors in the subependymal zone and subgranular zone of the adult brain. Here we provide ultrastructural evidence showing that highly proliferative precursors in the adult subependymal zone express dopamine receptors and receive dopaminergic afferents. Experimental depletion of dopamine in rodents decreases precursor cell proliferation in both the subependymal zone and the subgranular zone. Proliferation is restored completely by a selective agonist of D2-like (D2L) receptors. Experiments with neural precursors from the adult subependymal zone grown as neurosphere cultures confirm that activation of D2L receptors directly increases the proliferation of these precursors. Consistently, the numbers of proliferating cells in the subependymal zone and neural precursor cells in the subgranular zone and olfactory bulb are reduced in postmortem brains of individuals with Parkinson disease. These observations suggest that the generation of neural precursor cells is impaired in Parkinson disease as a consequence of dopaminergic denervation.</abstract><cop>New York</cop><pub>Nature Publishing Group US</pub><pmid>15195095</pmid><doi>10.1038/nn1265</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1097-6256 |
ispartof | Nature neuroscience, 2004-07, Vol.7 (7), p.726-735 |
issn | 1097-6256 1546-1726 |
language | eng |
recordid | cdi_proquest_miscellaneous_18014948 |
source | MEDLINE; SpringerLink Journals; Nature Journals Online |
subjects | Animal Genetics and Genomics Animals Antiparkinson Agents - therapeutic use Behavioral Sciences Biological Techniques Biomedical and Life Sciences Biomedicine Cell Differentiation Cell Division - drug effects Cell proliferation Cells, Cultured Diagnosis Dopamine Dopamine - deficiency Dopamine - physiology Dopamine Antagonists - pharmacology Drug Interactions Ependyma - cytology Ependyma - physiology Membrane Transport Proteins - metabolism Mice Mice, Inbred C57BL Neural Cell Adhesion Molecule L1 - metabolism Neurobiology Neurons - metabolism Neurons - pathology Neurons - ultrastructure Neurosciences Olfactory Bulb - cytology Olfactory Bulb - metabolism Parkinson Disease - drug therapy Parkinson Disease - metabolism Parkinson Disease - pathology Parkinson's disease Physiological aspects Rats Rats, Sprague-Dawley Risk factors Rodentia Tubulin - metabolism |
title | Dopamine depletion impairs precursor cell proliferation in Parkinson disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T03%3A24%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dopamine%20depletion%20impairs%20precursor%20cell%20proliferation%20in%20Parkinson%20disease&rft.jtitle=Nature%20neuroscience&rft.au=H%C3%B6glinger,%20G%C3%BCnter%20U&rft.date=2004-07-01&rft.volume=7&rft.issue=7&rft.spage=726&rft.epage=735&rft.pages=726-735&rft.issn=1097-6256&rft.eissn=1546-1726&rft.coden=NANEFN&rft_id=info:doi/10.1038/nn1265&rft_dat=%3Cgale_proqu%3EA185553435%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=251357416&rft_id=info:pmid/15195095&rft_galeid=A185553435&rfr_iscdi=true |